Profile data is unavailable for this security.
About the company
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing ViraxImmune with the intention of providing an immunology profiling platform that assesses each individual’s immune risk profile against global viral diseases as well as helping with the early diagnosis of post-viral syndromes associated with T cell exhaustion and chronic inflammation. Its product portfolio includes ViraxClear and ViraxVet. ViraxClear offers a range of accurate diagnostic testing kits and machines. ViraxVet offers various rapid and molecular tests for small animal veterinary diagnostics. The Company is initially focused on diseases associated with post-viral syndromes, including SARS-CoV-2, Human Papillomavirus (HPV), Malaria, Hepatitis B, and Herpes (HSV-1).
- Revenue in USD (TTM)2.99k
- Net income in USD-5.64m
- Incorporated2021
- Employees19.00
- LocationVirax Biolabs Group LtdBiocity Glasgow, Bo'ness Road, NewhouseLONDON ML1 5UHUnited KingdomGBR
- Phone+44 207 788 7414
- Websitehttps://www.viraxbiolabs.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Halberd Corp | 281.24k | 25.34k | 1.13m | 3.00 | 0.6897 | -- | 44.61 | 4.02 | 0.0023 | 0.0023 | 0.0018 | -0.0002 | 0.1449 | 0.0303 | 2.52 | -- | 1.31 | -- | 4.58 | -- | 50.00 | -- | 9.01 | -- | 0.2661 | 1.35 | 1.02 | -- | 271.52 | -- | -60.11 | -- | -- | -- |
| Pharmagreen Biotech Inc | 3.01k | -226.26k | 1.26m | 0.00 | -- | -- | 2.28 | 418.91 | -0.0003 | -0.0003 | 0.00 | -0.0035 | 0.0286 | 0.2026 | 0.0669 | -- | -214.92 | -709.50 | -- | -- | 44.85 | -- | -7,518.27 | -147,637.60 | 0.0375 | -- | -- | -- | 13.67 | -- | -76.59 | -- | -- | -- |
| Exousia Pro Inc | 0.00 | -854.02k | 1.35m | 0.00 | -- | -- | -- | -- | -0.0642 | -0.0642 | 0.00 | -0.0318 | 0.00 | -- | -- | -- | -1,313,877.00 | -- | -- | -- | -- | -- | -- | -- | -- | -1,816.06 | -- | -- | -- | -- | -248.31 | -- | -- | -- |
| International Stem Cell Corp | 9.39m | -149.00k | 1.40m | 32.00 | -- | -- | 8.70 | 0.1492 | -0.0187 | -0.0187 | 1.17 | 0.0655 | 1.80 | 2.66 | 11.08 | 293,468.80 | -1.13 | -16.11 | -10.84 | -52.88 | 57.86 | 59.53 | -0.6283 | -10.91 | 0.4604 | 0.6258 | 0.8632 | -- | 16.64 | -0.8308 | -59.54 | -- | -19.12 | -- |
| GlucoTrack Inc | 0.00 | -25.85m | 1.50m | 11.00 | -- | 0.5395 | -- | -- | -1,225.32 | -1,225.32 | 0.00 | 3.06 | 0.00 | -- | -- | 0.00 | -567.22 | -147.48 | -- | -192.87 | -- | -- | -- | -- | -- | -3.51 | 0.5422 | -- | -- | -- | -218.40 | -- | 34.73 | -- |
| Virax Biolabs Group Ltd | 2.99k | -5.64m | 1.53m | 19.00 | -- | 0.2545 | -- | 512.94 | -1.25 | -1.25 | 0.0007 | 0.8118 | 0.0004 | 0.5382 | 1.94 | 157.37 | -74.60 | -111.16 | -77.64 | -133.38 | -1,515.05 | -4.50 | -189,095.00 | -7,009.42 | 11.21 | -92.32 | 0.0959 | -- | -95.95 | -42.40 | 9.98 | -- | -- | -- |
| Ensysce Biosciences Inc | 4.49m | -10.97m | 1.54m | 7.00 | -- | 1.15 | -- | 0.3432 | -6.36 | -6.36 | 2.32 | 0.3783 | 0.7144 | -- | 5.02 | 641,138.60 | -174.67 | -48.70 | -270.43 | -62.66 | -- | -- | -244.49 | -501.34 | -- | -457.15 | 0.3071 | -- | 133.58 | -- | 24.83 | -- | -- | -- |
| Carisma Therapeutics Inc | 52.63m | 8.04m | 1.61m | 46.00 | 0.2047 | -- | 0.1687 | 0.0306 | 0.1881 | 0.1881 | 1.26 | -0.0208 | 2.17 | -- | -- | 1,144,174.00 | 33.09 | -26.58 | 51.48 | -30.35 | -- | -- | 15.28 | -169.12 | -- | -- | -- | -- | 31.59 | -- | 30.39 | -- | -1.99 | -- |
| Galera Therapeutics Inc | 0.00 | -8.99m | 1.66m | 3.00 | -- | -- | -- | -- | -0.1302 | -0.1302 | 0.00 | -1.94 | 0.00 | -- | -- | 0.00 | -129.27 | -96.94 | -145.04 | -116.42 | -- | -- | -- | -- | -- | -- | 34.30 | -- | -- | -- | 67.91 | -- | -- | -- |
| Clearmind Medicine Inc | 0.00 | -3.86m | 1.68m | -- | -- | 0.1485 | -- | -- | -30.64 | -30.64 | 0.00 | 7.54 | 0.00 | -- | -- | -- | -57.83 | -128.70 | -178.71 | -360.04 | -- | -- | -- | -- | -- | -- | 0.5987 | -- | -- | -- | 26.60 | -- | -- | -- |
| Agentix Corp | 0.00 | -655.59k | 1.68m | -- | -- | -- | -- | -- | -0.0164 | -0.0164 | 0.00 | -0.0853 | 0.00 | -- | -- | -- | -746.86 | -- | -- | -- | -- | -- | -- | -- | -- | -7.07 | -- | -- | -- | -- | 3.09 | -- | -- | -- |
| Hcw Biologics Inc | 422.03k | -22.21m | 1.76m | 36.00 | -- | -- | -- | 4.16 | -13.96 | -13.96 | 0.2716 | -0.8038 | 0.0162 | -- | 1.24 | 11,723.06 | -46.35 | -53.89 | -- | -66.10 | 20.00 | -- | -2,855.77 | -545.79 | -- | -42.26 | 1.45 | -- | -9.68 | -- | -20.12 | -- | -29.10 | -- |
| Zyversa Therapeutics Inc | 0.00 | -25.70m | 1.83m | 7.00 | -- | -- | -- | -- | -4.46 | -4.46 | 0.00 | -1.45 | 0.00 | -- | -- | 0.00 | -251.13 | -- | -- | -- | -- | -- | -- | -- | -- | -14.60 | -- | -- | -- | -- | 91.14 | -- | -- | -- |
| Bluejay Diagnostics Inc | 0.00 | -20.07m | 1.89m | 7.00 | -- | 0.2963 | -- | -- | -134.42 | -134.42 | 0.00 | 9.01 | 0.00 | -- | -- | 0.00 | -103.46 | -70.71 | -124.04 | -82.92 | -- | -- | -- | -12,694.84 | -- | -- | 0.0028 | -- | -- | -- | -110.38 | -- | 119.51 | -- |
| Yubo International Biotech Ltd | -20.00 | -1.23m | 1.96m | 18.00 | -- | -- | -- | -- | -0.0099 | -0.0099 | 0.00 | -0.0098 | -0.00002 | -0.0005 | -- | -1.11 | -105.87 | -- | -- | -- | -- | -- | -- | -- | 0.2394 | -- | -- | -- | -99.43 | -- | -48.55 | -- | -- | -- |
Data as of Feb 13 2026. Currency figures normalised to Virax Biolabs Group Ltd's reporting currency: US Dollar USD
2.28%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| HRT Financial LPas of 30 Sep 2025 | 60.07k | 1.38% |
| Virtu Americas LLCas of 30 Sep 2025 | 21.38k | 0.49% |
| National Bank Financial, Inc.as of 30 Sep 2025 | 10.00k | 0.23% |
| UBS Securities LLCas of 31 Dec 2025 | 7.49k | 0.17% |
| Farther Finance Advisors LLCas of 31 Dec 2025 | 21.00 | 0.00% |
| Citadel Securities LLCas of 30 Sep 2025 | 0.00 | 0.00% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
